News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN)'s Third Quarter 2012 Revenues Increased 10 Percent to $4.3 Billion and Adjusted Earnings Per Share (EPS) Increased 19 Percent to $1.67


10/24/2012 10:10:18 AM

Amgen (AMGN) today announced financial results for the third quarter of 2012. Key results for the quarter include: Total revenues increased 10 percent to $4,319 million, with 8 percent product sales growth driven by strong performance across the portfolio.

Read at BioSpace.com


comments powered by Disqus
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES